1. Volume 383, Issue 9930, Pages 1731-1738 (May 2014)
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial 
Dr Adriana H Tremoulet, MD, Sonia Jain, PhD, Preeti Jaggi, MD, Susan Jimenez-Fernandez, MD, Joan M Pancheri, RN, Xiaoying Sun, MS, John T Kanegaye, MD, John P Kovalchin, MD, Beth F Printz, MD, Prof Octavio Ramilo, MD, Prof Jane C Burns, MD 
The Lancet 
Volume 383, Issue 9930, Pages (May 2014)
DOI: /S (13)
Copyright © 2014 Elsevier Ltd Terms and Conditions

2. Figure
Trial profile
The Lancet  , DOI: ( /S (13) )
Copyright © 2014 Elsevier Ltd Terms and Conditions